FDA Law Blog

SEPTEMBER 20, 2021

Notable Dates and Timelines – Program opens, beginning of FY 2023; Expediting reviews fully implemented, by FY 2024; Webpage with detailed criteria for acceptance and participation, October 1, 2022; Interim assessment, end of FY 2025; Public workshop, end of Q2 FY 2026. Notable Dates and Timelines – New MAPP published, by Dec.

Patient-Centered 52

Patient-Centered Manufacturing Clinic Provider 52

Physician's Weekly

JUNE 17, 2025

Four individuals across two states have contracted the same strain of Salmonella. 19, 2026 (production code: 241019) and to thoroughly disinfect items and surfaces that may have come in contact with the product. The FDA is currently determining whether this lot is in distribution and if other lots or products are affected.

Illness 40

Illness Individual Hospital 40

Alabama Academy of Family Physicians

FEBRUARY 19, 2025

It then establishes a new Rural Physician Income Tax Credit program, effective January 1, 2026, that provides a $10,000 annual tax credit to qualifying rural physicians for up to four tax years. Under this program, qualifying hospitals would receive gifts to support their provision of acute care services to rural populations.

Insurance 130

Insurance Management Hospital Vaccination 130

ABIM

JUNE 11, 2025

After similar explorations in gastroenterology , hematology and medical oncology , ABIM announced the development of several new focused LKAs planned for launch in those areas in 2026. Society guests departed at this point in the meeting.

Board-Certified 52

Board-Certified Government Community Education 52

ABIM

JUNE 24, 2025

The group’s discussion centered on the roles that APPs play in individual members’ practices, the variety of practice structures and differences in how advanced practitioners are supervised or operate independently. There was agreement on a broad need for safe, structured, team-based care.

Board-Certified 40

Board-Certified Board-Certified Physicians Government Community 40

FDA Law Blog

JULY 7, 2024

2] The regulations require manufacturers to establish a “formally designated [complaint handling] unit,” [3] which can be accomplished by describing the unit in a procedure and/or including a diagram that identifies individuals, activities, and departments that are charged with “…receiving, reviewing, and evaluating” complaints. [4]

Manufacturing 64

Manufacturing Provider Physicals Electronics 64

GeriPal

APRIL 3, 2025

Annie 02:31 So if you go to the A G S meeting every year, you know that this group of three individuals comprises the AGS literature update. I will always, as always, say, you know, you’re welcome to do this in 2026. But in spite of that, it is a lot of work for three individuals to pull all this together. Of course.

IT 64

IT Hospital Screening Patients 64

FDA Law Blog

AUGUST 3, 2021

CMS estimated that the rule would result in savings in individual out-of-pocket costs but such savings would be more than offset by increased premiums. OIG argued that confidential manufacturer rebates to Medicare Part D plan sponsors and PBMs generally do not reduce patient out-of-pocket costs but act as kickbacks to these “middlemen.”

Manufacturing 52

Manufacturing Transportation Government Management 52

FDA Law Blog

SEPTEMBER 14, 2021

The most far reaching drug pricing provision of Subtitle E is an amendment to the Social Security Act to establish a Fair Price Negotiation Program applicable to Medicare Parts B and D as well as group and individual health plans in the commercial market. The Part B rebate would exclude vaccines as well.

Manufacturing 52

Manufacturing Insurance Government Patients 52

Physician's Weekly

JUNE 25, 2025

Dangerous changes loomed: To compensate for tax cuts for the wealthy, Trump’s “big, beautiful” bill and budget proposal for fiscal year 2026 threaten to curtail Medicaid, which provides health coverage for people with low incomes and disabilities. About 40% of adults with HIV rely on it for their lifesaving treatments.

Government 52

Government Community Family Families 52

FDA Law Blog

SEPTEMBER 13, 2021

A final OIG rule to change the structure of manufacturer rebates to Medicare Part D and Medicaid Managed Care plans and their PBMs is enmeshed in litigation and is likely to be at least postponed until 2026 (see our post ), and perhaps prevented from implementation altogether, by Congressional mandate.

Manufacturing 98

Manufacturing Supply Chain Patient-Centered Utilities 98